HEALTH

Bayer to Flee Drug Discovery with Google Cloud’s Excessive-Performance Compute Energy

Berlin, Germany and Sunnyvale, California, USA, January 11, 2023 – Bayer AG and Google Cloud this present day introduced a collaboration to power early drug discovery that will apply Google Cloud’s Tensor Processing Objects (TPUs), which are custom-developed accelerators designed to bustle cutting-edge machine studying objects and computationally-intensive workloads, to abet hump up and scale Bayer’s quantum chemistry calculations.

The belief of quantum mechanics applied to pc-aided drug discovery permits the in-silico modeling of biological and chemical programs with excessive accuracy, and therefore has the doable to abet title contemporary drug candidates. The goals of the collaboration are to hump up and scale quantum chemistry calculations the consume of Google Cloud’s TPUs and to repeat fully quantum mechanical modeling of protein-ligand interactions. The implications will resolve the scientific and economic viability of enormous-scale density functional theory calculations for supreme functions.

“Bayer’s aspiration to be amongst the leading innovators drives us to continue to put money into contemporary and disruptive applied sciences to cure complex problems,” mentioned Bijoy Sagar, Chief Recordsdata and Digital Transformation Officer at Bayer AG. “Partnering with Google Cloud on TPU powered quantum chemistry complements our ambition to work with alternate leaders and experts to immediate advise on digital transformation.”

“Accelerating drug discovery may well perhaps even be one of many perfect functions for AI and excessive performance computing within the healthcare alternate,” mentioned Thomas Kurian, CEO of Google Cloud. “Bringing Bayer’s highly efficient research and trend capabilities along with our alternate-leading infrastructure has the doable to liberate new discoveries – with higher accuracy and hump – serving to to receive medicines to patients faster.”

Increasing R&D effectivity to hump up trend of impactful medicines for patients in need is central to Bayer’s innovation device.

“By combining Google Cloud’s computing vitality with Bayer’s leading expertise in drug discovery we intend to unleash the probability of enormous-scale quantum chemistry,” mentioned Marianne De Backer, Head of Method, Industry Constructing & Licensing/Initiate Innovation and Member of the Executive Committee, Pharmaceuticals Division at Bayer AG. “Working with alternate leaders and pioneers to leverage scientific inclinations fueled by digital improvements is required to the latest and future of affected person care.”

About Bayer
Bayer is a world enterprise with core competencies within the lifestyles science fields of health care and diet. Its services and products and products are designed to abet other folks and the planet thrive by supporting efforts to master the predominant challenges offered by a increasing and extending older world inhabitants. Bayer is dedicated to driving sustainable trend and generating a constructive impact with its companies. On the same time, the Group goals to raise its earning vitality and develop cost thru innovation and enhance. The Bayer mark stands for have confidence, reliability and quality at some level of the enviornment. In fiscal 2021, the Group employed round 100,000 other folks and had sales of 44.1 billion euros. R&D prices earlier than special objects amounted to 5.3 billion euros. For added data, drag to www.bayer.com.

About Google Cloud
Google Cloud quickens every group’s potential to digitally transform its alternate. We advise enterprise-grade solutions that leverage Google’s cutting-edge technology – all on the cleanest cloud within the alternate. Customers in extra than 200 nations and territories flip to Google Cloud as their depended on accomplice to enable enhance and cure their most essential alternate problems.

Gain extra data at https://pharma.bayer.com/
Observe us on Facebook: http://www.facebook.com/bayer
Observe us on Twitter: @BayerPharma
 

Forward-Wanting Statements
This liberate can also simply maintain forward-having a uncover statements in step with latest assumptions and forecasts made by Bayer administration. Numerous known and unknown risks, uncertainties and a quantity of issues can also consequence in materials differences between the actual future outcomes, monetary scenario, trend or performance of the firm and the estimates given right here. These factors encompass those discussed in Bayer’s public experiences which are on hand on the Bayer internet website online at www.bayer.com. The firm assumes no liability whatsoever to change these forward-having a uncover statements or to adapt them to future events or inclinations.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button